| Online-Ressource |
Verfasst von: | Pan, Pei-Yin [VerfasserIn]  |
| Jonsson, Ulf [VerfasserIn]  |
| Çakmak, Sabriye Selin Şahpazoğlu [VerfasserIn]  |
| Häge, Alexander [VerfasserIn]  |
| Hohmann, Sarah [VerfasserIn]  |
| Norrman, Hjalmar Nobel [VerfasserIn]  |
| Buitelaar, Jan K. [VerfasserIn]  |
| Banaschewski, Tobias [VerfasserIn]  |
| Cortese, Samuele [VerfasserIn]  |
| Coghill, David [VerfasserIn]  |
| Bölte, Sven [VerfasserIn]  |
Titel: | Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis |
Verf.angabe: | Pei-Yin Pan, Ulf Jonsson, Sabriye Selin Şahpazoğlu Çakmak, Alexander Häge, Sarah Hohmann, Hjalmar Nobel Norrman, Jan K. Buitelaar, Tobias Banaschewski, Samuele Cortese, David Coghill and Sven Bölte |
Jahr: | 2022 |
Umfang: | 12 S. |
Fussnoten: | First published online: 12 October 2021 ; Gesehen am 25.05.2023 |
Titel Quelle: | Enthalten in: Psychological medicine |
Ort Quelle: | Cambridge : Cambridge University Press, 1970 |
Jahr Quelle: | 2022 |
Band/Heft Quelle: | 52(2022), 1, Seite 14-25 |
ISSN Quelle: | 1469-8978 |
Abstract: | There is mixed evidence on the association between headache and attention-deficit/hyperactivity disorder (ADHD), as well as headache and ADHD medications. This systematic review and meta-analysis investigated the co-occurrence of headache in children with ADHD, and the effects of ADHD medications on headache. Embase, Medline and PsycInfo were searched for population-based and clinical studies comparing the prevalence of headache in ADHD and controls through January 26, 2021. In addition, we updated the search of a previous systematic review and network meta-analysis of double-blind randomized controlled trials (RCTs) on ADHD medications on June 16, 2020. Trials of amphetamines, atomoxetine, bupropion, clonidine, guanfacine, methylphenidate, and modafinil with a placebo arm and reporting data on headache as an adverse event, were included. Thirteen epidemiological studies and 58 clinical trials were eligible for inclusion. In epidemiological studies, a significant association between headache and ADHD was found [odds ratio (OR) = 2.01, 95% confidence interval (CI) = 1.63-2.46], which remained significant when limited to studies reporting ORs adjusted for possible confounders. The pooled prevalence of headaches in children with ADHD was 26.6%. In RCTs, three ADHD medications were associated with increased headache during treatment periods, compared to placebo: atomoxetine (OR = 1.29, 95% CI = 1.06-1.56), guanfacine (OR = 1.43, 95% CI = 1.12-1.82), and methylphenidate (OR = 1.33, 95% CI = 1.09-1.63). The summarized evidence suggests that headache is common in children with ADHD, both as part of the clinical presentation as such and as a side effect of some standard medications. Monitoring and clinical management strategies of headache in ADHD, in general, and during pharmacological treatment are recommended. |
DOI: | doi:10.1017/S0033291721004141 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
kostenfrei: Volltext: https://doi.org/10.1017/S0033291721004141 |
| kostenfrei: Volltext: https://www.cambridge.org/core/journals/psychological-medicine/article/headache-in-adhd-as-comorbidity-and-a-side-effect ... |
| DOI: https://doi.org/10.1017/S0033291721004141 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | ADHD medication |
| attention-deficit/hyperactivity disorder |
| headache |
| meta-analysis |
| systematic review |
K10plus-PPN: | 1846225736 |
Verknüpfungen: | → Zeitschrift |
Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis / Pan, Pei-Yin [VerfasserIn]; 2022 (Online-Ressource)